Publications by authors named "Margot Drevait"
Background: infections remain difficult to manage in both cystic fibrosis (CF) and non-CF patients and reported clinical outcomes are largely unsatisfactory. Clinical trial data are limited and no approved therapies are currently available for the management of lung diseases. As an alternative, cohort studies may provide insightful information into the management of pulmonary disease.
View Article and Find Full Text PDFArticle Synopsis
- - Cystic fibrosis (CF) is a genetic disease primarily impacting the lungs and digestive system, and while there's no cure, specialized care has improved life expectancy significantly.
- - The study identified a DNA methylation biomarker that correlates with lung function, body mass index, and severity of CF symptoms, providing a potential tool for monitoring disease and treatment outcomes.
- - Researchers developed a straightforward method for assessing this biomarker and conducted a longitudinal analysis, which could help stratify CF patients for clinical trials in the future.